Importance

Loading Importance Indicators...

Abstract

New multilayer ocular implant devices are provided. In certain aspects, the device is adapted for residence in the sub-Tenon's space of a patient's eye. In certain systems, separate layers of the implant device will contain distinct therapeutic agents, for example two or more different agents that can deliver desirable pharmacological effects, in certain preferred systems, the distinct therapeutic agents in separate device layers may provide a coordinated pharmacological effect, for example a first layer may contain a primary therapeutic agent and a second layer may contain a therapeutic agent that provides a supportive benefit to the primary therapeutic agent such as reducing side effects or enhancing patient uptake of the primary therapeutic agent or other delivery enhancement.

Loading the Abstract Image...

First Claim